First Time Loading...

Pharmaron Beijing Co Ltd
SZSE:300759

Watchlist Manager
Pharmaron Beijing Co Ltd Logo
Pharmaron Beijing Co Ltd
SZSE:300759
Watchlist
Price: 19.75 CNY -1% Market Closed
Updated: May 2, 2024

Pharmaron Beijing Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Pharmaron Beijing Co Ltd
Operating Income Peer Comparison

Comparables:
603259
2269
300347
M
688114
W
2268

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Pharmaron Beijing Co Ltd
SZSE:300759
Operating Income
¥1.8B
CAGR 3-Years
18%
CAGR 5-Years
32%
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Operating Income
¥11.5B
CAGR 3-Years
52%
CAGR 5-Years
43%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Operating Income
¥4.4B
CAGR 3-Years
39%
CAGR 5-Years
45%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Operating Income
¥1.7B
CAGR 3-Years
21%
CAGR 5-Years
22%
CAGR 10-Years
34%
M
MGI Tech Co Ltd
SSE:688114
Operating Income
¥190.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
W
WuXi XDC Cayman Inc
HKEX:2268
Operating Income
¥147.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Pharmaron Beijing Co Ltd's Operating Income?
Operating Income
1.8B CNY

Based on the financial report for Dec 31, 2023, Pharmaron Beijing Co Ltd's Operating Income amounts to 1.8B CNY.

What is Pharmaron Beijing Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
32%

Over the last year, the Operating Income growth was 4%. The average annual Operating Income growth rates for Pharmaron Beijing Co Ltd have been 18% over the past three years , 32% over the past five years .